首页> 外国专利> POLYGENIC RISK SCORE MODIFIES RISK OF CORONARY ARTERY DISEASE CONFERRED BY LOW-DENSITY LIPOPROTEIN CHOLESTEROL

POLYGENIC RISK SCORE MODIFIES RISK OF CORONARY ARTERY DISEASE CONFERRED BY LOW-DENSITY LIPOPROTEIN CHOLESTEROL

机译:冠状动脉疾病 赋予 BY 低密度 脂蛋白胆固醇 多基因 风险评分 MODIFIES 风险

摘要

A method for a predictive prognosis of onset of a cardiovascular disease in an individual acquires/accesses low-density lipoprotein cholesterol level, calculating a risk value and determining an individualized risk value of onset of the cardiovascular disease, based on the calculated risk value. Calculating a risk value includes calculating the risk value representative for onset of the cardiovascular disease, based on operational values of a polygenic risk score and low-density lipoprotein cholesterol level, based on first, second and third risk parameters are representative of risk of onset of: the cardiovascular disease induced by the polygenic risk score, the cardiovascular disease induced by the low-density lipoprotein cholesterol level, and the cardiovascular disease induced by interaction of polygenic risk score and low-density lipoprotein cholesterol level. The risk parameters are calculated based on a pre-trained model and/or algorithm, to which the operational values of polygenic risk score and low-density lipoprotein cholesterol level are input.
机译:一种用于预测性的心血管疾病中的预测预测的方法获取/获得低密度脂蛋白胆固醇水平,基于计算的风险值计算风险值并确定心血管疾病发作的个性化风险值。计算风险值包括基于第一,第二和第三个风险参数的基于多种基因风险评分和低密度脂蛋白胆固醇水平的操作价值来计算心血管疾病发作的风险价值代表性。 :由多种子碱风险评分诱导的心血管疾病,由低密度脂蛋白胆固醇水平诱导的心血管疾病,以及通过多种基因风险评分的相互作用和低密度脂蛋白胆固醇水平诱导的心血管疾病。基于预先训练的模型和/或算法来计算风险参数,其中输入多种子基风险评分和低密度脂蛋白胆固醇水平的操作值。

著录项

  • 公开/公告号US2021280313A1

    专利类型

  • 公开/公告日2021-09-09

    原文格式PDF

  • 申请/专利权人 ALLELICA S.R.L.;

    申请/专利号US202117191004

  • 申请日2021-03-03

  • 分类号G16H50/20;G16B20;G16B40;G06N20;G16H50/30;

  • 国家 US

  • 入库时间 2022-08-24 20:55:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号